Wafaa Mamilli - Zoetis Chief EVP
| ZOE Stock | EUR 157.28 0.90 0.57% |
Insider
Wafaa Mamilli is Chief EVP of Zoetis Inc
| Age | 56 |
| Phone | 973 822 7000 |
| Web | https://www.zoetis.com |
Zoetis Management Efficiency
The company has return on total asset (ROA) of 0.1273 % which means that it generated a profit of $0.1273 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4719 %, meaning that it generated $0.4719 on every $100 dollars invested by stockholders. Zoetis' management efficiency ratios could be used to measure how well Zoetis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Teruyuki Masaka | Eisai Co | 45 | |
| Yosuke Akita | Eisai Co | 58 | |
| Yanhui Feng | Eisai Co | 51 | |
| Kenta Takahashi | Eisai Co | 64 | |
| Christopher OReilly | Takeda Pharmaceutical | N/A | |
| Gary Hendler | Eisai Co | 57 | |
| Erez MBA | Dr Reddys Laboratories | 55 | |
| Thomas Larsen | Swedish Orphan Biovitrum | 49 | |
| Torbjrn Hallberg | Swedish Orphan Biovitrum | 54 | |
| Deepak MBA | Dr Reddys Laboratories | 48 | |
| Nadeem Sarwar | Eisai Co | N/A | |
| Henrik Stenqvist | Swedish Orphan Biovitrum | 55 | |
| Seigo Izumo | Takeda Pharmaceutical | N/A | |
| Haruhiko Hirate | Takeda Pharmaceutical | 66 | |
| Pablo Mora | Swedish Orphan Biovitrum | 55 | |
| Gunupati BE | Dr Reddys Laboratories | 63 | |
| Norimasa Takeda | Takeda Pharmaceutical | N/A | |
| Andrew Plump | Takeda Pharmaceutical | 58 | |
| Sayoko Sasaki | Eisai Co | 55 | |
| Daniel Rankin | Swedish Orphan Biovitrum | 43 | |
| MS BTech | Dr Reddys Laboratories | 56 | |
Management Performance
| Return On Equity | 0.47 | |||
| Return On Asset | 0.13 |
Zoetis Inc Leadership Team
Elected by the shareholders, the Zoetis' board of directors comprises two types of representatives: Zoetis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zoetis. The board's role is to monitor Zoetis' management team and ensure that shareholders' interests are well served. Zoetis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zoetis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Frank, VP Relations | ||
| Kristin Peck, Executive Vice President and Presidentident - U.S. Operations | ||
| Wafaa Mamilli, Chief EVP | ||
| William Price, VP Officer | ||
| Roxanne Lagano, Chief Human Resource Officer, Executive Vice President | ||
| Jeannette Astorga, Exec Officer | ||
| Robert Polzer, Ex RD | ||
| Glenn David, CFO, Executive Vice President | ||
| Heidi Chen, Executive Vice President General Counsel, Corporate Secretary | ||
| Wetteny Joseph, Ex CFO |
Zoetis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zoetis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.47 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.26 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 71.14 B | |||
| Shares Outstanding | 463.39 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 94.44 % | |||
| Price To Earning | 36.15 X | |||
| Price To Book | 15.02 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zoetis Stock
When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.